|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM207675171 |
003 |
DE-627 |
005 |
20231224002559.0 |
007 |
cr uuu---uuuuu |
008 |
231224s2011 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2011.04.001
|2 doi
|
028 |
5 |
2 |
|a pubmed24n0692.xml
|
035 |
|
|
|a (DE-627)NLM207675171
|
035 |
|
|
|a (NLM)21514238
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Oettgen, Hans C
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Mast cells and tumour necrosis factor alpha (TNF-α)
|b partners in crime in asthma pathogenesis
|
264 |
|
1 |
|c 2011
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 11.08.2011
|
500 |
|
|
|a Date Revised 14.06.2011
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a CommentOn: Clin Immunol. 2011 Jul;140(1):18-25. - PMID 21459047
|
500 |
|
|
|a Citation Status MEDLINE
|
650 |
|
4 |
|a Comment
|
650 |
|
4 |
|a Editorial
|
650 |
|
7 |
|a Tumor Necrosis Factor-alpha
|2 NLM
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 140(2011), 1 vom: 20. Juli, Seite 1-2
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:140
|g year:2011
|g number:1
|g day:20
|g month:07
|g pages:1-2
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2011.04.001
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 140
|j 2011
|e 1
|b 20
|c 07
|h 1-2
|